Madrigal Pharmaceuticals Inc (MDGL) — Cash Flow-to-Debt Ratio
Madrigal Pharmaceuticals Inc (MDGL) has a Cash Flow-to-Debt Ratio of -0.20x as of December 2025, meaning its operating cash flow of $-133.46 Million could theoretically repay 0% of its total liabilities ($656.90 Million) in one year. See Madrigal Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Madrigal Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Madrigal Pharmaceuticals Inc across 23 annual periods. Also explore how fast is Madrigal Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Madrigal Pharmaceuticals Inc (2003–2025)
Year-by-year debt coverage analysis for Madrigal Pharmaceuticals Inc. For market capitalisation and broader financial context, see MDGL stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.29x | $-189.55 Million | $656.90 Million | ▲ +81.8% |
| 2024 | -1.58x | $-455.57 Million | $287.86 Million | ▼ -14.8% |
| 2023 | -1.38x | $-324.23 Million | $235.21 Million | ▼ -1.3% |
| 2022 | -1.36x | $-224.86 Million | $165.18 Million | ▲ +42.8% |
| 2021 | -2.38x | $-183.92 Million | $77.22 Million | ▲ +28.9% |
| 2020 | -3.35x | $-157.56 Million | $47.02 Million | ▼ -105.2% |
| 2019 | -1.63x | $-41.62 Million | $25.49 Million | ▲ +45.9% |
| 2018 | -3.02x | $-25.51 Million | $8.44 Million | ▼ -36.1% |
| 2017 | -2.22x | $-22.32 Million | $10.05 Million | ▲ +39.5% |
| 2016 | -3.67x | $-17.61 Million | $4.80 Million | ▲ +8.7% |
| 2015 | -4.02x | $-71.44 Million | $17.79 Million | ▼ -80.9% |
| 2014 | -2.22x | $-78.92 Million | $35.54 Million | ▼ -32.3% |
| 2013 | -1.68x | $-77.41 Million | $46.11 Million | ▲ +13.3% |
| 2012 | -1.94x | $-54.13 Million | $27.95 Million | ▼ -12.8% |
| 2011 | -1.72x | $-47.30 Million | $27.55 Million | ▼ -37.5% |
| 2010 | -1.25x | $-38.20 Million | $30.59 Million | ▼ -11.8% |
| 2009 | -1.12x | $-26.81 Million | $24.00 Million | ▼ -359.5% |
| 2008 | -0.24x | $-37.94 Million | $156.04 Million | ▼ -187.3% |
| 2007 | 0.28x | $27.22 Million | $97.75 Million | ▲ +129.7% |
| 2006 | -0.94x | $-52.98 Million | $56.54 Million | ▲ +71.6% |
| 2005 | -3.30x | $-61.88 Million | $18.73 Million | ▼ -37.5% |
| 2004 | -2.40x | $-33.80 Million | $14.06 Million | ▲ +64.4% |
| 2003 | -6.75x | $-23.61 Million | $3.50 Million | — |